EGFR and melanoma: Since some oncogenic signaling pathways, such as Wnt/β-catenin signaling, suppress tumor-derived chemokine expression in melanoma, which results in the reduction of tumor-infiltrating T cells (TILs)19, we speculated that EGFR signaling might also suppress some intrinsic chemokine production in human LA cells.